Onivyde Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

One 10 ml vial of concentrate contains 43 mg irinotecan anhydrous free base (as irinotecan sucrosofate salt in a pegylated liposomal formulation).
One ml of concentrate contains 4.3 mg irinotecan anhydrous free base (as irinotecan sucrosofate salt in a pegylated liposomal formulation).
The concentrate has a pH of 7.2 and an osmolality of 295 mOsm/kg.
Excipient with known effect: One ml of concentrate contains 0.144 mmol (3.31 mg) sodium.
Excipients/Inactive Ingredients: Liposome forming lipids: 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), Cholesterol, N-(carbonyl-methoxypolyethylene glycol-2000)-1, 2-distearoyl-sn-glycero-3-phosphoethanolamine (MPEG-2000-DSPE).
Other excipients: Sucrose octasulphate, 2-[4-(2-Hydroxyethyl)piperazin-1-yl] ethanesulfonic acid (HEPES buffer), Sodium chloride, Water for injections.

irinotecan

Manufacturer:

Servier

Distributor:

Zuellig Pharma